title: Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance.
abstract: Recent evidence indicates that an imbalance between cardiomyocyte hypertrophy and blood vessel growth in the remote myocardium may contribute to heart failure in ischaemic heart disease. It remains, however, largely unknown which angiogenic factors are capable of stimulating vessel growth in the remote myocardium after myocardial infarction (MI) and whether systemic, rather than local, administration of such factors suffices to ameliorate post-MI cardiac recovery. We therefore analysed the effect of systemic placental growth factor (PlGF) delivery on myocardial recovery post-MI in mice. MI was induced by permanent ligation of the left anterior descending coronary (LAD) artery in C57Bl6/J mice, followed by systemic injection of a PlGF adenovirus, resulting in elevated circulating levels of PlGF for 4 weeks. Functional and morphological analysis revealed that PlGF treatment induced cardiomyocyte hypertrophy and improved cardiac recovery at day 28 post-MI. PlGF stimulated angiogenesis in the infarct border and vessel enlargement in the remote myocardium. In this mouse model, capillary-to-cardiomyocyte ratios in the remote myocardium were maintained post-MI, but PlGF increased the vascular perfusion area in balance with the cardiomyocyte hypertrophy. Overall, systemic delivery of PlGF improves cardiac performance and promotes adaptive remodelling of the post-MI heart.
authors: Vesalius Research Center (VRC), VIB, 3000 Leuven, Belgium.
authors: C
authors: C
authors: Roncal
authors: I
authors: I
authors: Buysschaert
authors: Ek
authors: E
authors: Chorianopoulos
authors: M
authors: M
authors: Georgiadou
authors: O
authors: O
authors: Meilhac
authors: M
authors: M
authors: Demol
authors: J-B
authors: JB
authors: Michel
authors: S
authors: S
authors: Vinckier
authors: L
authors: L
authors: Moons
authors: P
authors: P
authors: Carmeliet
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D000704:Analysis of Variance; D000818:Animals; D003331:Coronary Vessels / Q000473:pathology; D004452:Echocardiography; D005260:Female; D015316:Genetic Therapy / Q000379:methods*; D008026:Ligation; D051379:Mice; D008810:Mice, Inbred C57BL; D023421:Models, Animal; D009203:Myocardial Infarction / Q000378:metabolism* / Q000473:pathology; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D000072483:Placenta Growth Factor; D011257:Pregnancy Proteins / Q000235:genetics*; D013995:Time; D014161:Transduction, Genetic / Q000379:methods
chemical_list: C000608037:Pgf protein, mouse; D011257:Pregnancy Proteins; D000072483:Placenta Growth Factor